Placenta is a new innovative source of stem cells – mesenchymal stem cells, blood-forming cells and endothelial progenitors.
It can be kept for a long time at very low temperatures (the same as umbilical cord blood and umbilical cord tissue). Therapeutic application is expected particularly in regenerative medicine.
Mesenchymal stem cells: are among the most promising type of cells for cell therapy and regenerative treatment of damaged organs. The ability to differentiate into cartilage cells, bone, skin, fat, muscle, heart, or the immunosuppressive and immunomodulating abilities of mesenchymal stem cells can help in chronic inflammatory and autoimmune processes.
Blood-forming stem cells: the results of several studies have confirmed that placenta is an important source of blood-forming stem cells suitable for transplantation.
Endothelial progenitor cells: help in forming new blood vessels and also have the ability to repair blood cells. Studies have shown that placental tissue can be regarded as a rich source of endothelial progenitor cells necessary for the proper functioning of the blood flow and for remedying damage caused by arterial diseases, such as stroke, heart attack, peripheral arterial disease etc.Current use and clinical studies of stem cells